2015 - Fellow of the Australian Academy of Health and Medical Science
The scientist’s investigation covers issues in Macular degeneration, Visual acuity, Ophthalmology, Internal medicine and Surgery. Her Macular degeneration research is mostly focused on the topic Choroidal neovascularization. Robyn H. Guymer has researched Visual acuity in several fields, including Adverse effect, Left eye, Randomized controlled trial and Age related.
The concepts of her Ophthalmology study are interwoven with issues in Retina and Maculopathy. Her research integrates issues of Dietary fat, Clinical trial, Environmental health and Risk factor in her study of Surgery. Robyn H. Guymer works mostly in the field of Drusen, limiting it down to concerns involving Pathology and, occasionally, Retinal and Macular telangiectasia.
Her primary areas of study are Macular degeneration, Ophthalmology, Age related, Visual acuity and Internal medicine. Her Macular degeneration study incorporates themes from Prospective cohort study and Surgery. Her study in Ophthalmology is interdisciplinary in nature, drawing from both Maculopathy and Atrophy.
Her work on Geographic atrophy as part of general Age related study is frequently linked to In patient, bridging the gap between disciplines. Her research in Visual acuity intersects with topics in Optometry and Randomized controlled trial. Her Internal medicine research is multidisciplinary, incorporating elements of Endocrinology and Oncology.
Robyn H. Guymer mostly deals with Macular degeneration, Ophthalmology, Age related, Visual acuity and Drusen. Her work on Choroidal neovascularization as part of general Macular degeneration research is often related to Ranibizumab, thus linking different fields of science. Many of her research projects under Ranibizumab are closely connected to Pediatrics, Cohort and Retrospective cohort study with Pediatrics, Cohort and Retrospective cohort study, tying the diverse disciplines of science together.
Her work on Reticular pseudodrusen is typically connected to Subthreshold conduction, In patient and Multimodal imaging as part of general Age related study, connecting several disciplines of science. Her Visual acuity research incorporates themes from Night vision, Luminance, Optometry, Randomized controlled trial and Prospective cohort study. Her research investigates the link between Drusen and topics such as Fundus that cross with problems in Maculopathy.
Robyn H. Guymer focuses on Macular degeneration, Visual acuity, Ophthalmology, Retinal and Drusen. In her works, Robyn H. Guymer undertakes multidisciplinary study on Macular degeneration and Ranibizumab. Her Visual acuity research integrates issues from Clinical trial, MEDLINE, Regimen, Randomized controlled trial and Age related.
Her Ophthalmology research incorporates elements of Lesion, Prospective cohort study and Functional recovery. Her work in the fields of Retinal, such as Retinal pigment epithelium, Microperimetry and Reticular pseudodrusen, overlaps with other areas such as Recovery rate and Test point. Her Drusen research is multidisciplinary, incorporating perspectives in Optical coherence tomography, Activities of daily living, Confounding and Confidence interval.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Seven new loci associated with age-related macular degeneration
Lars G. Fritsche;Lars G. Fritsche;Wei Chen;Wei Chen;Matthew Schu;Brian L. Yaspan.
Nature Genetics (2013)
A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants
Lars G. Fritsche;Wilmar Igl;Jessica N.Cooke Bailey;Felix Grassmann.
Nature Genetics (2016)
A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy.
Edwin M. Stone;Andrew J. Lotery;Francis L. Munier;Elise Héon.
Nature Genetics (1999)
Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE study.
Ursula Schmidt-Erfurth;Bora Eldem;Robyn Guymer;Jean-François Korobelnik.
Safety and efficacy of a flexible dosing regimen of ranibizumab in neovascular age-related macular degeneration: the SUSTAIN study.
Frank G. Holz;Winfried Amoaku;Juan Donate;Robyn H. Guymer.
Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis.
Elaine W-T Chong;Andréas Josef Kreis;Tien Y Wong;Julie A Simpson.
Archives of Ophthalmology (2008)
Automatic segmentation of nine retinal layer boundaries in OCT images of non-exudative AMD patients using deep learning and graph search.
Leyuan Fang;David Cunefare;Chong Wang;Robyn H. Guymer.
Biomedical Optics Express (2017)
Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration
Yi Yu;Tushar R. Bhangale;Jesen Fagerness;Jesen Fagerness;Stephan Ripke;Stephan Ripke.
Human Molecular Genetics (2011)
The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration.
Paul N Baird;Elizabeth Guida;Diep T Chu;Hien T V Vu.
Investigative Ophthalmology & Visual Science (2004)
Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis
Elaine W-T Chong;Tien Y Wong;Andréas Josef Kreis;Julie A Simpson.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: